Ligand validation:6AK8

8DG: 8-OXO-2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE

8DG is a Ligand Of Interest in 6AK8 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AK8_8DG_A_504	83%	7%	0.107	0.967	2.01	2.9	8	12	0	0	100%	1
7KT3_8DG_A_501	98%	29%	0.058	0.984	1.24	1.57	4	5	0	0	100%	1
7KTJ_8DG_A_506	98%	43%	0.064	0.987	0.86	1.32	-	3	0	0	100%	1
7KTK_8DG_A_501	90%	18%	0.091	0.974	0.88	2.57	1	8	0	0	100%	1
6AK9_8DG_A_503	90%	8%	0.099	0.982	2	2.63	6	9	0	0	100%	1
7KT4_8DG_A_512	89%	52%	0.086	0.964	0.55	1.27	-	5	2	0	100%	0.44
5GG6_8DG_A_401	98%	8%	0.059	0.979	2.02	2.55	6	12	0	0	100%	1
4XA5_8DG_A_601	94%	8%	0.064	0.963	2.14	2.42	8	12	0	0	100%	0.94
5GG8_8DG_A_401	94%	6%	0.079	0.978	1.97	2.97	6	12	1	0	100%	1
7X9H_8DG_A_202	93%	22%	0.075	0.969	0.97	2.26	2	13	0	0	100%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.